Management of Symptomatic Hiatal Hernia Recurrence

Evaluation and Classification of Recurrent Hiatal Hernia

• The American Gastroenterological Association recommends that hiatal hernia with erosive esophagitis grade B or higher or elevated acid exposure confirms diagnosis of ERGE and requires continuous treatment with proton pump inhibitors (PPIs) 1
• The presence of a large hiatal hernia with esophagitis grade C or D, bipositional reflux, or extreme levels of acid exposure represents a more severe phenotype of ERGE 1

Optimization of Lifestyle

• Weight reduction in patients with obesity is essential to reduce intra-abdominal pressure 1
• Elevating the head of the bed (15-20 cm) helps prevent nocturnal reflux 1
• Avoiding large meals 3 hours before bedtime reduces nocturnal symptoms 1
• Implementing diaphragmatic breathing techniques can strengthen the anti-reflux barrier 1
• Patient education on the mechanisms of ERGE and hiatal hernia is essential to improve treatment adherence 2

Optimization of PPI Therapy

• Ensuring adequate dosing time of PPI (30-60 minutes before meals) to maximize efficacy 1, 3
• Considering dose escalation or switching to another PPI if response is inadequate after 4-8 weeks of treatment 1, 3
• Patients with erosive esophagitis grade B or higher, Barrett's esophagus, or peptic stricture require long-term PPI therapy without dose reduction 1, 3
• Severe ERGE associated with large hiatal hernia requires indefinite PPI therapy 1, 3

Adjuvant Pharmacological Therapy

• Alginate-based antacids are useful for breakthrough symptoms, especially in patients with known hiatal hernia 3
• H2 antagonists may be useful for nocturnal symptoms, although use is limited by tachyphylaxis 3
• Baclofen may be effective for predominant regurgitation or belching symptoms, although limited by side effects 3
• In cases of esophageal hypersensitivity or hypervigilance, consider neuromodulation with low-dose antidepressants 3

Additional Evaluation in Case of Inadequate Response

• If symptoms persist despite treatment optimization, consider:
  • Upper endoscopy to evaluate mucosal integrity 4
  • High-resolution manometry to evaluate esophageal peristaltic function and exclude achalasia 4
  • 24-hour pH-impedance monitoring with PPI to determine the mechanism of persistent symptoms 4
  • Gastric emptying study if concomitant gastroparesis is suspected 4

Considerations for Surgical Treatment

• Surgery should be considered in patients with refractory ERGE despite optimized medical treatment 1
• In patients with altered esophageal motility, partial fundoplications may be considered 1
• Transoral incisionless fundoplication is an endoscopic option for carefully selected patients with ERGE in the absence of hiatal hernia 4, 5

Follow-up and Monitoring

• Routine reevaluation of treatment and adjustment of PPI to the effective lowest dose when there is adequate response 1, 3
• Monitoring of persistent symptoms with endoscopy and esophageal physiological studies 1
• Consideration of behavioral interventions such as cognitive-behavioral therapy, hypnotherapy, and diaphragmatic breathing techniques in patients with esophageal hypersensitivity component 3